EVAX ▲ +1.9% - Evaxion A/S
$EVAX - Evaxion applies its AI-Immunology™ platform in autoimmune diseases
Evaxion shares rose 1.9% following the company's announcement that it is applying its AI-Immunology platform to autoimmune disease research, expanding the potential application scope of its proprietary technology beyond its current focus areas.
14-SEP-2026 08:00 AM ET
Share this post
More filings for $EVAX
EVAX ▼ -2.2% - Evaxion A/SOct 23, 2026EVAX ▲ +15.7% - Evaxion A/SOct 19, 2026EVAX ▲ +4.1% - Evaxion A/SOct 2, 2026
View full $EVAX filing history →💬 Comments
Loading comments…
Leave a comment
